Table 1.
Severe cCSC | Non-severe cCSC | aCSC | Controls ARMS2 and CFH | Controls C4B | Controls NR3C2 | |
No. of subjects | 173 | 272 | 135 | 826 | 250 | 1,385 |
No. of male subjects | 151 (87%) | 216 (79%) | 92 (68%) | 424 (51%) | 198 (79%) | 635 (46%) |
Mean age ± SD (years) | 54 ± 10 | 51 ± 10 | 47 ± 10 | 64 ± 12 | 51 ± 10 | 51 ± 10 |
ARMS2, age-related maculopathy susceptibility 2; CFH, complement factor H; C4B, complement component 4; NR3C2, nuclear receptor subfamily 3 Group C member 2.